$289.26 3.76 (1.32%)
18:29 EDT HUM Stock Quote Delayed 15 Minutes
Previous Close $289.26
Market Cap 39.83B
PE Ratio 22.51
Volume (Avg. Vol.) 1.88M
Day's Range 282.82 - 290.00
52-Week Range 225.65 - 355.88
Dividend & Yield 1.40 (0.48%)
HUM Stock Predictions, Articles, and Humana News
- From InvestorPlace
- From the Web
Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.
News that a Centene-Humana deal isn't in the works has CNC stock falling on Monday after an official statement was made by Humana.
These healthcare stocks have each hit a rough road for various reasons. Here's what investors need to know about each.
Trade war fears have been keeping markets volatile for some time now. So it makes sense to add stocks with domestic focus to your portfolio right away. Compare....
ANTM is a boring stock but that does not exclude it from being a great one. After the first quarter results and 2018 outlook, investors should take a look at this company.
Walmart (WMT) is reportedly in talks to acquire health insurer Humana (HUM), but the finer details of the discussions are still unknown.
Humana stock is down just a bit today following its earnings report, extending a recent pullback, because the market can't quite figure out where HUM is going.
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength. Compare Brokers...
Rite Aid bulls hope it finds a buyer, while bears see it circling the drain. RAD stock might be fun to trade right now, but watch it closely.
Amazon (AMZN) could face probe over Prime delivery times, CSX's (CSX) CEO died over the weekend and Humana (HUM) is in talks to buy Kindred (KND).
Humana Inc (NYSE:HUM) is ranked as a Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking HUM has had from Portfolio Grader for the last month.
Humana Inc (NYSE:HUM) is one of 82 companies within the Health Care Providers & Services GICS industry group, which is in turn part of the 782 company GICS Health Care sector. HUM has a market value of $36.9 billion which is in the top decile in its industry group. Portfolio Grader's current ranking for HUM puts it 21 among the 82 companies in this industry group, placing it in the top half; in the top quartile of the sector with a ranking of 182 among the 782 companies in the sector, and number 1,004 in the nearly 5,000 company Portfolio Grader universe.
Portfolio Grader currently ranks Humana Inc (NYSE:HUM) a Buy. The approach to investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. HUM has recently seen its Portfolio Grader rating downgraded over the last month from a Strong Buy to a Buy.
Humana Inc (NYSE:HUM) is one of the 781 companies in the GICS Health Care sector, and a constituent of the 82 company Health Care Providers & Services GICS industry group within this sector. HUM's market value is $33.4 billion which places it in the top 10% of its industry group. Portfolio Grader's current ranking for HUM puts it 16 among the 82 companies in this industry group, putting in the top quartile; in the top quartile of the sector with a ranking of 150 among the 781 companies in the sector, and number 974 in the nearly 5,000 company Portfolio Grader universe.
Humana Inc (NYSE:HUM) is a $34.9 billion in market value member of the Health Care Providers & Services GICS industry group where Portfolio Grader's current ranking for HUM puts it 17 among the 82 companies in this industry group, giving it a well above-average position. HUM is ranked in the top quartile of the sector with a ranking of 89 among the 782 companies in the sector and number 577 in the 5000 company Portfolio Grader company universe.
From Seeking Alpha
From Seeking Alpha
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!